The Global Fund has been backing away from efforts to promote generic competition

Reprinted from original source, Global Fund Observer, Issue 284 6 April 2016: The Global Fund has been backing away from efforts to promote generic competition  Fund’s strategy has come under growing scrutiny by Nathalie Abejero With progressively stricter patent protections, the costs for new treatments continue to rise. It is a global problem that affects countries across income levels, but is particularly challenging for poor and transitioning economies. Until recently, The Global Fund has advocated for the affordability, availability, and financing of medicines and other health commodities, taking the time-tested position of promoting generic competition as the most effective means for bringing down the price of … [Read more...]